Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.6 USD | +1.97% | +0.02% | -7.74% |
05-14 | Transcript : The Clorox Company Presents at Goldman Sachs Global Staples Forum, May-14-2024 08:15 AM | |
05-08 | Visa, PNC, Synchrony Among Companies Targeted in Cyberattack Campaign | MT |
Sales 2024 * | 7.17B 563B | Sales 2025 * | 7.38B 579B | Capitalization | 16.34B 1,281B |
---|---|---|---|---|---|
Net income 2024 * | 227M 17.8B | Net income 2025 * | 733M 57.49B | EV / Sales 2024 * | 2.61 x |
Net Debt 2024 * | 2.42B 190B | Net Debt 2025 * | 2.32B 182B | EV / Sales 2025 * | 2.53 x |
P/E ratio 2024 * |
72.3
x | P/E ratio 2025 * |
22.2
x | Employees | 8,100 |
Yield 2024 * |
3.65% | Yield 2025 * |
3.8% | Free-Float | 94.83% |
Latest transcript on The Clorox Company
1 day | +1.97% | ||
1 week | +0.02% | ||
1 month | -5.81% | ||
3 months | -13.49% | ||
6 months | -8.54% | ||
Current year | -7.74% |
Managers | Title | Age | Since |
---|---|---|---|
Linda Rendle
CEO | Chief Executive Officer | 46 | 31/12/02 |
Kevin Jacobsen
DFI | Director of Finance/CFO | 57 | 31/12/94 |
Michael Ott
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Allan Mackay
BRD | Director/Board Member | 68 | 14/08/16 |
Director/Board Member | 71 | 30/06/15 | |
Director/Board Member | 66 | 30/06/15 |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 131.6 | +1.97% | 1,858,727 |
30/05/24 | 129 | +0.63% | 964,578 |
29/05/24 | 128.2 | -0.51% | 1,386,223 |
28/05/24 | 128.9 | -2.02% | 1,254,521 |
Delayed Quote Nyse, May 31, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.74% | 16.34B | |
-17.86% | 39.79B | |
+13.17% | 26.17B | |
-11.61% | 7.33B | |
+5.96% | 5.98B | |
-6.01% | 3.05B | |
-2.83% | 2.22B | |
-15.86% | 1.77B | |
+35.60% | 1.05B | |
+2.84% | 663M |
- Stock Market
- Equities
- CLX Stock